109 related articles for article (PubMed ID: 7913248)
1. Natural killer cell stimulatory factor (NKSF)/IL-12 and cytolytic activities of PBL/NK cells from human immunodeficiency virus type-1 infected patients.
Sirianni MC; Ansotegui IJ; Aiuti F; Wigzell H
Scand J Immunol; 1994 Jul; 40(1):83-6. PubMed ID: 7913248
[TBL] [Abstract][Full Text] [Related]
2. Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients.
Chehimi J; Starr SE; Frank I; Rengaraju M; Jackson SJ; Llanes C; Kobayashi M; Perussia B; Young D; Nickbarg E
J Exp Med; 1992 Mar; 175(3):789-96. PubMed ID: 1346797
[TBL] [Abstract][Full Text] [Related]
3. Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin-12) on cell-mediated cytotoxicity against tumor-derived and virus-infected cells.
Chehimi J; Valiante NM; D'Andrea A; Rengaraju M; Rosado Z; Kobayashi M; Perussia B; Wolf SF; Starr SE; Trinchieri G
Eur J Immunol; 1993 Aug; 23(8):1826-30. PubMed ID: 8102101
[TBL] [Abstract][Full Text] [Related]
4. Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF.
Robertson MJ; Soiffer RJ; Wolf SF; Manley TJ; Donahue C; Young D; Herrmann SH; Ritz J
J Exp Med; 1992 Mar; 175(3):779-88. PubMed ID: 1346796
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 12 augments natural killer-cell mediated cytotoxicity in hairy cell leukemia.
Bigda J; Mysliwska J; Dziadziuszko R; Bigda J; Mysliwski A; Hellmann A
Leuk Lymphoma; 1993 May; 10(1-2):121-5. PubMed ID: 8104069
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of natural killer activity in peripheral blood lymphocytes of healthy donors and melanoma patients in vitro: synergism between interleukin (IL)-12 and IL-15 or IL-12 and IL-2.
Seidel MG; Freissmuth M; Pehamberger H; Micksche M
Naunyn Schmiedebergs Arch Pharmacol; 1998 Sep; 358(3):382-9. PubMed ID: 9774227
[TBL] [Abstract][Full Text] [Related]
7. Natural killer cell stimulatory factor (NKSF) augments natural killer cell and antibody-dependent tumoricidal response against colon carcinoma cell lines.
Lieberman MD; Sigal RK; Williams NN; Daly JM
J Surg Res; 1991 Apr; 50(4):410-5. PubMed ID: 1673486
[TBL] [Abstract][Full Text] [Related]
8. Natural-killer cell-derived cytolytic molecules in HIV-associated pulmonary tuberculosis-role of exogenous interleukins.
Rao PV; Ramanavelan S; Rajasekaran S; Raja A
J Clin Immunol; 2010 May; 30(3):393-401. PubMed ID: 20229057
[TBL] [Abstract][Full Text] [Related]
9. Role of the production of natural killer cell stimulatory factor (NKSF/IL-12) in the ability of B cell lines to stimulate T and NK cell proliferation.
Valiante NM; Rengaraju M; Trinchieri G
Cell Immunol; 1992 Nov; 145(1):187-98. PubMed ID: 1358460
[TBL] [Abstract][Full Text] [Related]
10. Human immunodeficiency virus (HIV) type-1 GP120-specific cell-mediated cytotoxicity (CMC) and natural killer (NK) activity in HIV-infected (HIV+) subjects: enhancement with interleukin-2(IL-2), IL-12, and IL-15.
Lin SJ; Roberts RL; Ank BJ; Nguyen QH; Thomas EK; Stiehm ER
Clin Immunol Immunopathol; 1997 Feb; 82(2):163-73. PubMed ID: 9000485
[TBL] [Abstract][Full Text] [Related]
11. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes.
Kobayashi M; Fitz L; Ryan M; Hewick RM; Clark SC; Chan S; Loudon R; Sherman F; Perussia B; Trinchieri G
J Exp Med; 1989 Sep; 170(3):827-45. PubMed ID: 2504877
[TBL] [Abstract][Full Text] [Related]
12. Cellular and molecular mechanisms of activation of MHC nonrestricted cytotoxic cells by IL-12.
Cesano A; Visonneau S; Clark SC; Santoli D
J Immunol; 1993 Sep; 151(6):2943-57. PubMed ID: 8104216
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of natural killer cell activities from normal donors and AIDS patients by envelope peptides from human immunodeficiency virus type I.
Nair MP; Schwartz SA
Cell Mol Biol (Noisy-le-grand); 1997 Nov; 43(7):969-79. PubMed ID: 9449529
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of IFN-gamma induction by natural killer cell stimulatory factor (NKSF/IL-12). Role of transcription and mRNA stability in the synergistic interaction between NKSF and IL-2.
Chan SH; Kobayashi M; Santoli D; Perussia B; Trinchieri G
J Immunol; 1992 Jan; 148(1):92-8. PubMed ID: 1345792
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-12 (IL-12) augments cytolytic activity of natural killer cells toward Mycobacterium tuberculosis-infected human monocytes.
Denis M
Cell Immunol; 1994 Jul; 156(2):529-36. PubMed ID: 7913000
[TBL] [Abstract][Full Text] [Related]
16. Cooperation of natural killer cell stimulatory factor/interleukin-12 with other stimuli in the induction of cytokines and cytotoxic cell-associated molecules in human T and NK cells.
Aste-Amezaga M; D'Andrea A; Kubin M; Trinchieri G
Cell Immunol; 1994 Jul; 156(2):480-92. PubMed ID: 7912999
[TBL] [Abstract][Full Text] [Related]
17. Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells.
D'Andrea A; Rengaraju M; Valiante NM; Chehimi J; Kubin M; Aste M; Chan SH; Kobayashi M; Young D; Nickbarg E
J Exp Med; 1992 Nov; 176(5):1387-98. PubMed ID: 1357073
[TBL] [Abstract][Full Text] [Related]
18. Induction mechanism of human blood CD8+ T cell proliferation and cytotoxicity by natural killer cell stimulatory factor (interleukin-12).
Nabioullin R; Sone S; Nii A; Haku T; Ogura T
Jpn J Cancer Res; 1994 Aug; 85(8):853-61. PubMed ID: 7928632
[TBL] [Abstract][Full Text] [Related]
19. Anticryptococcal activity of NK cell-enriched peripheral blood lymphocytes from human immunodeficiency virus-infected subjects: responses to interleukin-2, interferon-gamma, and interleukin-12.
Horn CA; Washburn RG
J Infect Dis; 1995 Oct; 172(4):1023-7. PubMed ID: 7561175
[TBL] [Abstract][Full Text] [Related]
20. HIV infection and natural killer cytotoxicity in hemophilic patients.
de la Barrera SS; Olabuenaga SE; Soria A; Felippo M; Perez Bianco R; de Bracco MM
Immunol Lett; 1990 Jun; 24(3):207-15. PubMed ID: 2384263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
